This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated AURKB Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-AURKB WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~39.3 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Appendix (IHC candidate; verify WB) +4 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 5 isoform(s) |
The A00762 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | H1792 (40ug), HCT116 (40ug), LOVO (40ug) (catalog A00762) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A00762; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
AURKB is predicted at 39.3 kDa; isoforms could affect migration, but no empirical band or distinct isoform pattern is supplied.
| Band near 39.3 kDa | Consistent with the predicted AURKB mass; confirm identity with controls |
| Several bands at different positions | Could reflect AURKB splice isoforms, though distinct migration is unproven |
| Band below 39.3 kDa | Could be an AURKB isoform; its mass is not supplied |
| Band above 39.3 kDa | Could be an AURKB isoform; its mass is not supplied |
| UniProt predicted mass | Places the reference band near 39.3 kDa |
| Splice isoform 1 | Its individual mass and migration relative to other isoforms are unknown |
| Splice isoforms 2 and 3 | Their individual masses and migration relative to other isoforms are unknown |
| Splice isoforms 4 and 5 | Their individual masses and migration relative to other isoforms are unknown |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Nuclear and chromosome-associated AURKB may be poorly recovered | Check extraction of the nuclear fraction and use a positive-control lysate |
| Band higher than expected | Isoform identity or nonspecific binding is unresolved | Compare with an AURKB depletion control |
| Band lower than expected | An isoform or degradation could account for the band | Check sample integrity and compare with an AURKB depletion control |
| Multiple bands | Five annotated isoforms exist, but their migration is unknown | Identify AURKB-dependent bands with a depletion control |
| Weak or no signal | AURKB may be poorly recovered from nuclear material | Verify nuclear extraction and test a positive-control lysate |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | endocrine cells | High | Protein (IHC) | HPA → |
| Colon | endocrine cells | High | Protein (IHC) | HPA → |
| Duodenum | endocrine cells | High | Protein (IHC) | HPA → |
| Rectum | endocrine cells | High | Protein (IHC) | HPA → |
| Skin | cells in basal layer | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Caudate | glial cells | Not detected | Protein (IHC) | HPA → |
| Cerebellum | cells in granular layer | Not detected | Protein (IHC) | HPA → |
| Cervix | glandular cells | Not detected | Protein (IHC) | HPA → |
| Epididymis | glandular cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for AURKB, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
All four listed antibodies have WB images. A00762 and A00762-1 show AURKB/C (K197) blots of named whole-cell lysates. M00762-1 shows an approximately 39 kDa band in human lysates. A00762T232 shows phospho-Thr232 detection in treated COS7 lysate with phosphopeptide blocking. Evidence is limited to the shown conditions.
Which to pick: For phospho-Thr232, choose A00762T232. For Aurora B in human lysates, M00762-1 has a documented 39 kDa band. A00762 and A00762-1 list human, mouse, and rat reactivity; compare their pictured lysates with your planned sample.